Answers are grounded in this paper and cite their sources.
Early administration of SAV reduces the risk of complications. The presence of leucocytosis and severe coagulopathy can predict adverse outcomes.
No takes yet. Share an insight, caveat, or question.
Suchithra et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: